- Home
- CLLS vs FRPH Comparison
CLLS vs FRPH Comparison
Compare CLLS & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLLS | FRPH |
|---|---|---|
| Founded | 1999 | 1986 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.4M | 420.6M |
| IPO Year | 2014 | 1995 |
Fundamental Metrics
Financial Performance| Metric | CLLS | FRPH |
|---|---|---|
| Price | $1.25 | $20.09 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $5.33 | N/A |
| AVG Volume (30 Days) | ★ 191.3K | 89.1K |
| Earning Date | 11-06-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $42,846,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.70 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.57 |
| 52 Week Low | $1.22 | $19.60 |
| 52 Week High | $5.48 | $25.74 |
Technical Indicators
Market Signals| Indicator | CLLS | FRPH |
|---|---|---|
| Relative Strength Index (RSI) | 21.90 | 31.20 |
| Support Level | $1.25 | N/A |
| Resistance Level | $2.99 | $24.51 |
| Average True Range (ATR) | 0.08 | 0.38 |
| MACD | 0.03 | -0.07 |
| Stochastic Oscillator | 7.63 | 21.63 |
Price Performance
Historical ComparisonAbout CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, industrial, and office (the Development Segment), and (iv) management of mixed-use residential/retail properties owned through joint ventures.